Data is not available at this time.
AID Life Science Holdings Limited operates as a specialized investment manager, providing a suite of financial services primarily in Hong Kong with an international scope. Its core revenue model is derived from asset management, investment advisory, and corporate services, supplemented by fund administration and wealth management offerings. The company also maintains a portfolio of available-for-sale investments, which contributes to its earnings. Operating within the highly competitive and regulated financial services sector, the firm positions itself as a niche player catering to specific client needs rather than competing with large-scale institutional asset managers. Its market position is characterized by its smaller scale and focused service offerings, which may appeal to a targeted clientele seeking personalized investment management and advisory services in the Asian financial markets.
The company reported revenue of HKD 19.98 million for FY 2021. Despite this modest top-line figure, it demonstrated strong profitability with net income of HKD 18.53 million, indicating efficient cost management. However, operating cash flow was negative at HKD -9.48 million, suggesting potential challenges in cash generation from core operations during this period.
The company generated diluted EPS of HKD 0.0335, reflecting its earnings capacity relative to its equity base. The significant disparity between revenue and net income suggests substantial non-operating income sources, likely from its investment portfolio. Capital expenditures were minimal at HKD -78,000, indicating a capital-light business model focused primarily on financial assets rather than physical infrastructure.
The balance sheet shows HKD 29.51 million in cash against total debt of HKD 168.06 million, indicating a leveraged position. The high debt level relative to cash reserves warrants attention, though the company's profitability provides some capacity to service obligations. The composition of assets appears heavily weighted toward financial investments rather than operating assets.
No dividend was distributed during the period, consistent with the company's focus on retaining earnings. The financial profile suggests a strategy oriented toward investment growth rather than income distribution to shareholders. Historical trends would be needed to assess longer-term growth patterns and capital allocation priorities.
With a reported market capitalization of zero, this likely indicates either data unavailability or a delisted status. The beta of 0.19 suggests lower volatility relative to the market, but without valid market cap data, conventional valuation metrics cannot be meaningfully calculated or interpreted for this period.
The company's strategic position lies in its specialized investment management services and portfolio holdings. Its outlook depends on investment performance and ability to navigate competitive financial markets. The negative operating cash flow and leveraged balance sheet present challenges that management must address through improved operational efficiency and prudent capital management.
Company filingsFinancial data provider
show cash flow forecast
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |